Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane: Critical dependence on 2,3-butanediyl linker absolute configuration
- 23 August 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (4) , 543-549
- https://doi.org/10.1016/0006-2952(96)00305-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)Biochemical Pharmacology, 1995
- Quinobenoxazines: A Class of Novel Antitumor Quinolones and Potent Mammalian DNA Topoisomerase II Catalytic InhibitorsBiochemistry, 1994
- SV40 DNA replication intermediates: Analysis of drugs which target mammalian DNA replicationBioEssays, 1993
- A simple route to optically pure 2,3-diaminobutaneTetrahedron: Asymmetry, 1991
- Two-dimensional agarose gel analysis of simian virus 40 DNA replication intermediatesMethods, 1991
- Rapid evaluation of topoisomerase inhibitors: Caffeine inhibition of topoisomerases in vivoTeratogenesis, Carcinogenesis, and Mutagenesis, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.Molecular and Cellular Biology, 1986
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969
- Stereoisomeric 2,3-Butanediamines, 3-Amino-2-butanols and 2,3-Dimethylethyleneimines; Stereochemistry of the Opening and Closing of the Imine Ring1Journal of the American Chemical Society, 1952